vs

Side-by-side financial comparison of IPG PHOTONICS CORP (IPGP) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

IPG PHOTONICS CORP is the larger business by last-quarter revenue ($274.5M vs $220.8M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs 4.8%, a 1.0% gap on every dollar of revenue. On growth, IPG PHOTONICS CORP posted the faster year-over-year revenue change (17.1% vs 9.6%). IPG PHOTONICS CORP produced more free cash flow last quarter ($10.9M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 4.4%).

IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

IPGP vs UTI — Head-to-Head

Bigger by revenue
IPGP
IPGP
1.2× larger
IPGP
$274.5M
$220.8M
UTI
Growing faster (revenue YoY)
IPGP
IPGP
+7.5% gap
IPGP
17.1%
9.6%
UTI
Higher net margin
UTI
UTI
1.0% more per $
UTI
5.8%
4.8%
IPGP
More free cash flow
IPGP
IPGP
$30.1M more FCF
IPGP
$10.9M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
4.4%
IPGP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IPGP
IPGP
UTI
UTI
Revenue
$274.5M
$220.8M
Net Profit
$13.3M
$12.8M
Gross Margin
36.1%
Operating Margin
1.2%
7.1%
Net Margin
4.8%
5.8%
Revenue YoY
17.1%
9.6%
Net Profit YoY
69.8%
-42.1%
EPS (diluted)
$0.30
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IPGP
IPGP
UTI
UTI
Q4 25
$274.5M
$220.8M
Q3 25
$250.8M
$222.4M
Q2 25
$250.7M
$204.3M
Q1 25
$227.8M
$207.4M
Q4 24
$234.3M
$201.4M
Q3 24
$233.1M
$196.4M
Q2 24
$257.6M
$177.5M
Q1 24
$252.0M
$184.2M
Net Profit
IPGP
IPGP
UTI
UTI
Q4 25
$13.3M
$12.8M
Q3 25
$7.5M
$18.8M
Q2 25
$6.6M
$10.7M
Q1 25
$3.8M
$11.4M
Q4 24
$7.8M
$22.2M
Q3 24
$-233.6M
$18.8M
Q2 24
$20.2M
$5.0M
Q1 24
$24.1M
$7.8M
Gross Margin
IPGP
IPGP
UTI
UTI
Q4 25
36.1%
Q3 25
39.5%
Q2 25
37.3%
Q1 25
39.4%
Q4 24
38.6%
Q3 24
23.2%
Q2 24
37.3%
Q1 24
38.7%
Operating Margin
IPGP
IPGP
UTI
UTI
Q4 25
1.2%
7.1%
Q3 25
3.1%
11.2%
Q2 25
0.0%
6.9%
Q1 25
0.8%
8.1%
Q4 24
6.0%
13.6%
Q3 24
-108.7%
13.3%
Q2 24
4.7%
4.2%
Q1 24
7.6%
6.1%
Net Margin
IPGP
IPGP
UTI
UTI
Q4 25
4.8%
5.8%
Q3 25
3.0%
8.4%
Q2 25
2.6%
5.2%
Q1 25
1.6%
5.5%
Q4 24
3.3%
11.0%
Q3 24
-100.2%
9.6%
Q2 24
7.8%
2.8%
Q1 24
9.6%
4.2%
EPS (diluted)
IPGP
IPGP
UTI
UTI
Q4 25
$0.30
$0.23
Q3 25
$0.18
$0.33
Q2 25
$0.16
$0.19
Q1 25
$0.09
$0.21
Q4 24
$0.27
$0.40
Q3 24
$-5.33
$0.35
Q2 24
$0.45
$0.09
Q1 24
$0.52
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IPGP
IPGP
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$839.3M
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$2.1B
$335.9M
Total Assets
$2.4B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IPGP
IPGP
UTI
UTI
Q4 25
$839.3M
$162.8M
Q3 25
$870.4M
$169.1M
Q2 25
$899.6M
$70.7M
Q1 25
$926.9M
$96.0M
Q4 24
$930.2M
$172.0M
Q3 24
$1.0B
$161.9M
Q2 24
$1.1B
$115.5M
Q1 24
$1.1B
$116.1M
Total Debt
IPGP
IPGP
UTI
UTI
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
IPGP
IPGP
UTI
UTI
Q4 25
$2.1B
$335.9M
Q3 25
$2.1B
$328.1M
Q2 25
$2.1B
$306.8M
Q1 25
$2.1B
$293.9M
Q4 24
$2.0B
$280.0M
Q3 24
$2.1B
$260.2M
Q2 24
$2.3B
$239.4M
Q1 24
$2.3B
$232.6M
Total Assets
IPGP
IPGP
UTI
UTI
Q4 25
$2.4B
$834.0M
Q3 25
$2.4B
$826.1M
Q2 25
$2.4B
$740.8M
Q1 25
$2.3B
$720.4M
Q4 24
$2.3B
$753.8M
Q3 24
$2.4B
$744.6M
Q2 24
$2.5B
$706.0M
Q1 24
$2.6B
$702.1M
Debt / Equity
IPGP
IPGP
UTI
UTI
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IPGP
IPGP
UTI
UTI
Operating Cash FlowLast quarter
$28.8M
$3.1M
Free Cash FlowOCF − Capex
$10.9M
$-19.2M
FCF MarginFCF / Revenue
4.0%
-8.7%
Capex IntensityCapex / Revenue
6.5%
10.1%
Cash ConversionOCF / Net Profit
2.17×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$-3.5M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IPGP
IPGP
UTI
UTI
Q4 25
$28.8M
$3.1M
Q3 25
$35.3M
$57.1M
Q2 25
$-2.2M
$18.1M
Q1 25
$13.4M
$-789.0K
Q4 24
$73.8M
$23.0M
Q3 24
$66.1M
$67.5M
Q2 24
$53.5M
$10.0M
Q1 24
$54.6M
$-2.5M
Free Cash Flow
IPGP
IPGP
UTI
UTI
Q4 25
$10.9M
$-19.2M
Q3 25
$14.6M
$40.6M
Q2 25
$-17.6M
$6.8M
Q1 25
$-11.4M
$-11.7M
Q4 24
$50.6M
$19.6M
Q3 24
$43.0M
$60.0M
Q2 24
$29.2M
$3.0M
Q1 24
$26.5M
$-8.4M
FCF Margin
IPGP
IPGP
UTI
UTI
Q4 25
4.0%
-8.7%
Q3 25
5.8%
18.3%
Q2 25
-7.0%
3.4%
Q1 25
-5.0%
-5.7%
Q4 24
21.6%
9.7%
Q3 24
18.4%
30.6%
Q2 24
11.3%
1.7%
Q1 24
10.5%
-4.6%
Capex Intensity
IPGP
IPGP
UTI
UTI
Q4 25
6.5%
10.1%
Q3 25
8.3%
7.4%
Q2 25
6.1%
5.5%
Q1 25
10.9%
5.3%
Q4 24
9.9%
1.7%
Q3 24
9.9%
3.8%
Q2 24
9.4%
4.0%
Q1 24
11.1%
3.2%
Cash Conversion
IPGP
IPGP
UTI
UTI
Q4 25
2.17×
0.24×
Q3 25
4.73×
3.04×
Q2 25
-0.34×
1.69×
Q1 25
3.58×
-0.07×
Q4 24
9.44×
1.04×
Q3 24
3.58×
Q2 24
2.65×
2.01×
Q1 24
2.27×
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IPGP
IPGP

Materials Processing$232.8M85%
Laser And Non Laser Systems$38.8M14%
Transferred Over Time$5.3M2%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons